IMGN — ImmunoGen Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapMomentum Trap

Annual balance sheet for ImmunoGen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	262	176	294	479	275
Net Total Accounts Receivable
Net Total Receivables	12.1	27.2	22.5	13.9	18
Total Inventory
Prepaid Expenses
Total Current Assets	279	209	324	500	304
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.9	22.6	19.8	17.1	14.6
Other Long Term Assets
Total Assets	295	235	355	526	349
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	70.7	77.4	122	101	122
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	284	311	266	200	193
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	11	-76.1	89.6	326	156
Total Liabilities & Shareholders' Equity	295	235	355	526	349
Total Common Shares Outstanding